— Know what they know.
Not Investment Advice

006280.KS KSC

GC Biopharma Corp.
1W: +2.0% 1M: -1.8% 3M: +1.4% YTD: -25.6% 1Y: -6.5% 3Y: +13.3% 5Y: -60.5%
₩125,800.00 ($93.59)
-3500.00 (-2.71%)
 
Weekly Expected Move ±3.9%
₩115884 ₩120842 ₩125800 ₩130758 ₩135716
KSC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 49 · ₩1.44T mcap · 5M float · 0.970% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩1.44T ($1.1B)
52W Range105900-183800
Volume14,875
Avg Volume52,877
Beta0.73
Dividend₩1500.00
Analyst Ratings
No analyst coverage
Company Info
CEOHuh Eun-chul
Employees2,351
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2000-01-04
107, Ihyeon-ro 30beon-gil, Giheung-gu
Yongin-Si, GY 16924
KR
82 3 1260 9300
About GC Biopharma Corp.

GC Biopharma Corp. is a pharmaceutical enterprise primarily involved in the production and distribution of various medical products. Its extensive portfolio encompasses specialized treatments for blood-related conditions, non-prescription remedies, general medications, and immunizations, among other therapeutic solutions. The company was established on November 1, 1969, and its principal corporate offices are situated in Yongin, South Korea.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms